Departments of Chemistry and Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, United States.
Innovative Genomics Institute, Berkeley, California 94720, United States.
J Am Chem Soc. 2024 Sep 11;146(36):24788-24799. doi: 10.1021/jacs.3c12389. Epub 2024 Aug 28.
14-3-3 proteins have a unique ability to bind and sequester a multitude of diverse phosphorylated signaling proteins and transcription factors. Many previous studies have shown that interactions of 14-3-3 with specific phosphorylated substrate proteins can be enhanced through small-molecule natural products or fully synthetic molecular glue interactions. However, enhancing 14-3-3 interactions with both therapeutically intractable transcription factor substrates and potential neo-substrates to sequester and inhibit their function remains elusive. One of the 14-3-3 proteins, 14-3-3σ or SFN, has cysteine C38 at the substrate-binding interface, near the sites where previous 14-3-3 molecular glues have been found to bind. In this study, we screen a fully synthetic cysteine-reactive covalent ligand library to identify molecular glues that enhance the interaction of 14-3-3σ with not only druggable transcription factors such as estrogen receptor (ERα) but also challenging oncogenic transcription factors such as YAP and TAZ, which are part of the Hippo transducer pathway. We identify a hit EN171 that covalently targets both C38 and C96 on 14-3-3 to enhance 14-3-3 interactions with ERα, YAP, and TAZ, leading to impaired estrogen receptor and Hippo pathway transcriptional activity. We further demonstrate that EN171 could not only be used as a molecular glue to enhance native protein interactions but could also be used as a covalent 14-3-3 recruiter in heterobifunctional molecules to sequester nuclear neo-substrates such as BRD4 and BLC6 into the cytosol. Overall, our study reveals a covalent ligand that acts as a novel 14-3-3 molecular glue for challenging transcription factors such as YAP and TAZ and demonstrates that these glues can be potentially utilized in heterobifunctional molecules to sequester nuclear neo-substrates out of the nucleus and into the cytosol to enable targeted protein localization.
14-3-3 蛋白具有独特的能力,可以结合和隔离多种不同的磷酸化信号蛋白和转录因子。许多先前的研究表明,通过小分子天然产物或全合成分子胶相互作用,可以增强 14-3-3 与特定磷酸化底物蛋白的相互作用。然而,增强 14-3-3 与治疗上难以处理的转录因子底物以及潜在的新底物的相互作用,以隔离并抑制其功能仍然难以实现。14-3-3 蛋白之一,14-3-3σ 或 SFN,在底物结合界面上具有半胱氨酸 C38,靠近先前发现 14-3-3 分子胶结合的位点。在这项研究中,我们筛选了一个全合成的半胱氨酸反应性共价配体文库,以鉴定增强 14-3-3σ 与不仅是可药物靶标转录因子(如雌激素受体(ERα))而且是具有挑战性的致癌转录因子(如 YAP 和 TAZ)相互作用的分子胶,这些因子是 Hippo 转导途径的一部分。我们鉴定出一个命中化合物 EN171,它共价靶向 14-3-3 的 C38 和 C96,以增强 14-3-3 与 ERα、YAP 和 TAZ 的相互作用,导致雌激素受体和 Hippo 途径转录活性受损。我们进一步证明,EN171 不仅可以用作增强天然蛋白相互作用的分子胶,还可以用作异双功能分子中的共价 14-3-3 招募剂,将核新底物(如 BRD4 和 BLC6)隔离到细胞质中。总的来说,我们的研究揭示了一种共价配体,它可以作为一种新型的 14-3-3 分子胶,用于具有挑战性的转录因子,如 YAP 和 TAZ,并证明这些胶可以潜在地用于异双功能分子中,将核新底物隔离出细胞核并进入细胞质,以实现靶向蛋白定位。